ZIP-kinase Activators
The chemical class referred to as ZIP-kinase Activators constitutes a diverse set of compounds designed to modulate the activity of ZIP-kinase, a protein encoded by the DAPK3 gene. ZIP-kinase, also known as death-associated protein kinase 3 (DAPK3), plays a central role in cellular processes, particularly those related to actomyosin dynamics and cell motility. The class includes several compounds with unique mechanisms of action, providing researchers with a nuanced toolkit for exploring the intricacies of ZIP-kinase regulation. ZIP-kinase activators act through the inhibition of myosin light chain kinase (MLCK) or Rho-associated protein kinase (ROCK). For instance, activators inhibit MLCK, indirectly activating ZIP-kinase and initiating phosphorylation events that modulate actomyosin contraction. Similarly, they can also act as ROCK inhibitors, by impacting ZIP-kinase activity, influencing cellular processes tied to cytoskeletal rearrangement and cell motility.
ZIP-kinase Activators intervene in the mevalonate pathway. Activators of this class can inhibits farnesyl pyrophosphate synthase (FPPS) and HMG-CoA reductase. By disrupting protein prenylation processes, these compounds may indirectly affect ZIP-kinase function, influencing cellular processes associated with cytoskeletal dynamics and migration. The versatility of the ZIP-kinase Activators class is further exemplified by each targeting distinct signaling pathways. In addition, activators showcase varied mechanisms for ZIP-kinase activation, affecting actomyosin dynamics and cellular processes related to cytoskeletal organization and motility. Lastly, activators can inhibit geranylgeranyltransferase I (GGTase I), presenting an alternative route for potential ZIP-kinase activation. In essence, the ZIP-kinase Activators class provides a comprehensive suite of tools for researchers to decipher the intricate regulatory networks governing ZIP-kinase function, shedding light on the molecular mechanisms underpinning actomyosin dynamics and cellular motility.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is a potential ZIP-kinase activator that inhibits myosin light chain kinase (MLCK). By inhibiting MLCK, ML-7 indirectly activates ZIP-kinase, promoting phosphorylation events that regulate cellular processes related to actomyosin contraction and cytoskeletal dynamics. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic Acid, a bisphosphonate, may act as a ZIP-kinase activator by influencing the mevalonate pathway. As an inhibitor of farnesyl pyrophosphate synthase (FPPS), it disrupts protein prenylation, potentially impacting ZIP-kinase activity and downstream signaling related to cellular processes such as migration and apoptosis. | ||||||
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $199.00 $1165.00 | 1 | |
GSK269962A is a potential activator of ZIP-kinase that acts through Rho-associated protein kinase (ROCK) inhibition. By blocking ROCK, GSK269962A can indirectly activate ZIP-kinase, affecting actomyosin dynamics and cellular processes associated with cell motility and morphology. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a selective ROCK inhibitor, represents a potential ZIP-kinase activator. By inhibiting ROCK, Y-27632 can indirectly activate ZIP-kinase, impacting actin cytoskeleton dynamics and cellular processes related to migration, adhesion, and contraction. | ||||||
H-1152 dihydrochloride | 451462-58-1 | sc-203592 sc-203592A | 1 mg 5 mg | $104.00 $364.00 | 7 | |
H-1152 is a potential ZIP-kinase activator acting through inhibition of ROCK. Its impact on ROCK inhibition can lead to downstream activation of ZIP-kinase, influencing actomyosin dynamics and cellular processes associated with cytoskeletal rearrangement and motility. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin, a statin, is a potential ZIP-kinase activator through its inhibition of the mevalonate pathway. By inhibiting HMG-CoA reductase, Simvastatin disrupts protein prenylation, potentially influencing ZIP-kinase activity and cellular processes related to actin dynamics and motility. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Fasudil is a potential activator of ZIP-kinase through its role as a ROCK inhibitor. By inhibiting ROCK, Fasudil can indirectly activate ZIP-kinase, impacting cellular processes associated with actomyosin contractility, cytoskeletal dynamics, and cell motility. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is a potential ZIP-kinase activator acting through inhibition of protein kinase A (PKA). By blocking PKA, H-89 may indirectly activate ZIP-kinase, affecting cellular processes related to cytoskeletal organization and motility. | ||||||
GGTI-2133 | 1217480-14-2 | sc-221668 sc-221668A | 1 mg 5 mg | $219.00 $632.00 | 2 | |
GGTI-2133 is a potential ZIP-kinase activator through inhibition of geranylgeranyltransferase I (GGTase I). By disrupting protein geranylgeranylation, GGTI-2133 may impact ZIP-kinase activity and cellular processes associated with cytoskeletal rearrangement and motility. | ||||||
Thiazovivin | 1226056-71-8 | sc-361380 sc-361380A | 10 mg 25 mg | $284.00 $634.00 | 15 | |
Thiazovivin is a potential activator of ZIP-kinase acting through Rho-associated protein kinase (ROCK) inhibition. By blocking ROCK, Thiazovivin can indirectly activate ZIP-kinase, influencing actomyosin dynamics and cellular processes related to cell motility and morphology. | ||||||